The subcellular fractions containing protein kinases capable of phosph
orylating basic fibroblast growth factor (FGF-2) are unknown, but havi
ng previously characterized one that is associated with the plasma mem
brane [1991, Mol. Endocrinol, 5, 1003-1012] we evaluated the catalytic
properties of another in the nucleus. The reaction is time (linear up
to 15 min), enzyme (2,000-25,000 nuclei/ml), and substrate (K(m) 0.18
muM) dependent, and the targets serine. DNase pretreatment of nuclei
decreases the incorporation of phosphate into FGF-2 by 50% and the rea
ction. It is also inhibited by heparin (EC50 1 mug/ml) and spermidine
(EC50 3 muM). Calcium and cAMP have no effect. We conclude that the ki
nase is distinct from PKA, and PKC, and suggest that changes in glycos
aminoglycan and polyamine concentrations during the cell cycle may mod
ulate FGF-2 phosphorylation in the nucleus, or as it is translocated t
o the nucleus.